Developing a new nanoemulsion drug product for herpes simplex virus
Official title: Task V23: Storage and product formulation (Formulation of gD2 Nanoemulsion Drug Product)
Funded at Advanced Bioscience Laboratories, INC. · NIH-10489234 · Data updated 2026-11-12
This study is working on a new medicine in tiny droplets to help treat herpes infections, and it's designed to make sure the product is safe and effective for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2021 |
| Award (this year) | $105,984 |
| NIH project number | 272201800009I-P00001-759302000003-1 |
| Project ID | NIH-10489234 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from herpes simplex virus infections.
✕Less likely to help
Patients with other types of viral infections unrelated to herpes simplex may not benefit from this research.
What this research studies
This research focuses on the formulation and manufacturing of a nanoemulsion drug product aimed at treating herpes simplex virus infections. It involves a series of processes including product development planning, optimization, and compliance with good manufacturing practices (cGMP) for clinical studies. Patients may benefit from the development of new vaccines and biologics that target infectious diseases, particularly those caused by herpes simplex virus. The research also includes regulatory support to ensure that the products meet FDA standards.
Why it matters
Potential benefit: If successful, this research could lead to effective new treatments for herpes simplex virus infections.
How similar studies have gone: Previous research has shown success in developing vaccines and biologics for infectious diseases, indicating a promising approach in this area.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Tim — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tim
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.